All Updates

All Updates

icon
Filter
Funding
Future Fields raises USD 11.2 million in funding
Cell-cultured Meat
Feb 22, 2023
This week:
M&A
Stripe to acquire stablecoin platform Bridge for USD 1 billion
FinTech Infrastructure
Yesterday
Partnerships
Intuitive AI partner with Moda Center to implement Oscar Sort recycling technology
Waste Recovery & Management Tech
Yesterday
Management news
Funding
Minze Health raises USD 5.3 million in funding for product and market expansion; appoints new VP
Preventive Healthcare
Yesterday
Partnerships
Firefly Aerospace partners with True Anomaly for Space Force rapid-response mission launches
Space Travel and Exploration Tech
Yesterday
Funding
zkPass raises USD 12.5 million in Series A funding
Enterprise Blockchain Solutions
Yesterday
Partnerships
Ontada partners with Microsoft to process unstructured oncology data using Azure AI
Clinical Trial Technology
Yesterday
Product updates
Burcon unveils canola protein isolate for egg replacement
Plant-based Dairy & Egg
Yesterday
Product updates
Bene Meat Technologies produces first cultivated burger at parity with premium beef
Cell-cultured Meat
Yesterday
Geographic expansion
Regulation/policy
The Better Meat Co. expands to Asia with Singapore approval for Rhiza mycoprotein
Plant-based Meat
Yesterday
Listing
Pony.ai files for US IPO
Auto Tech
Yesterday
Cell-cultured Meat

Cell-cultured Meat

Feb 22, 2023

Future Fields raises USD 11.2 million in funding

Funding

  • Future Fields has raised USD 11.2 million in funding from venture capitalists and government contracts, including Bee Partners, Toyota Ventures, Builders VC, and AgFunder, and others.

  • The company will use the funds to open a production facility and scale its team with a focus on creating biomolecules using its EntoEngine™ technology. The technology uses fruit flies to create key biomolecules for various industries, including cultured meat, medical research, and biopharmaceuticals, which are faster and more scalable than traditional bioreactors.

  • Founded in 2018, Future Fields claims to provide a more sustainable and cost-effective way to produce recombinant proteins for cell culture, with a smaller greenhouse gas footprint than existing bioreactor technology. The company's technology is said to quickly add more supply with minimal investment and have better control over the quality of its product, making it an attractive solution to meet the growing demand for bioreactors.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.